1. Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms.
- Author
-
Chen, Jinjin, Huang, Qingxia, Li, Jing, Yao, Yao, Sun, Weichen, Zhang, Zepeng, Qi, Hongyu, Chen, Zhaoqiang, Liu, Jiaqi, Zhao, Daqing, Mi, Jia, and Li, Xiangyan
- Subjects
- *
THERAPEUTIC use of ginseng , *POLYSACCHARIDES , *ONLINE information services , *CYTOKINES , *EVALUATION of medical care , *CLINICAL drug trials , *POLYPHENOLS , *MEDICAL information storage & retrieval systems , *SYSTEMATIC reviews , *MYOCARDIAL infarction , *GLYCOSIDES , *APOPTOSIS , *MYOCARDIAL reperfusion complications , *OXIDATIVE stress , *CLINICAL medicine , *DRUG development , *MEDLINE , *GINSENG - Abstract
Panax ginseng C. A. Meyer (P. ginseng) is effective in the prevention and treatment of myocardial ischemia-reperfusion (I/R) injury. The mechanism by which P. ginseng exerts cardioprotective effects is complex. P. ginseng contains many pharmacologically active ingredients, such as molecular glycosides, polyphenols, and polysaccharides. P. ginseng and each of its active components can potentially act against myocardial I/R injury. Myocardial I/R was originally a treatment for myocardial ischemia, but it also induced irreversible damage, including oxygen-containing free radicals, calcium overload, energy metabolism disorder, mitochondrial dysfunction, inflammation, microvascular injury, autophagy, and apoptosis. This study aimed to clarify the protective effects of P. ginseng and its active ingredients against myocardial I/R injury, so as to provide experimental evidence and new insights for the research and application of P. ginseng in the field of myocardial I/R injury. This review was based on a search of PubMed, NCBI, Embase, and Web of Science databases from their inception to February 21, 2022, using terms such as "ginseng," "ginsenosides," and "myocardial reperfusion injury." In this review, we first summarized the active ingredients of P. ginseng , including ginsenosides, ginseng polysaccharides, and phytosterols, as well as the pathophysiological mechanisms of myocardial I/R injury. Importantly, preclinical models with myocardial I/R injury and potential mechanisms of these active ingredients of P. ginseng for the prevention and treatment of myocardial disorders were generally summarized. P. ginseng and its active components can regulate oxidative stress related proteins, inflammatory cytokines, and apoptosis factors, while protecting the myocardium and preventing myocardial I/R injury. Therefore, P. ginseng can play a role in the prevention and treatment of myocardial I/R injury. P. ginseng has a certain curative effect on myocardial I/R injury. It can prevent and treat myocardial I/R injury in several ways. When ginseng exerts its effects, should be based on the theory of traditional Chinese medicine and with the help of modern medicine; the clinical efficacy of P. ginseng in preventing and treating myocardial I/R injury can be improved. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF